KRAS and cancer: Besides, recent research discovered that lack of glutamine could induce KRas-driven S-phase arrest in cancer cells, which is caused by inadequate nucleotide biosynthesis30; besides, these arrested cells are more sensitive to cytotoxic drugs such as rapamycin, paclitaxel, and capecitabine31–33, Consequently, blocking glutamine metabolism.